KLOR-CON is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, Llc. The primary component is Potassium Chloride.
Product ID | 43353-064_5c5d42ca-d5b6-481d-b121-f7cd027fad06 |
NDC | 43353-064 |
Product Type | Human Prescription Drug |
Proprietary Name | KLOR-CON |
Generic Name | Potassium Chloride |
Dosage Form | Tablet, Film Coated, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2014-09-01 |
Marketing Category | NDA / NDA |
Application Number | NDA019123 |
Labeler Name | Aphena Pharma Solutions - Tennessee, LLC |
Substance Name | POTASSIUM CHLORIDE |
Active Ingredient Strength | 750 mg/1 |
Pharm Classes | Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2015-06-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA019123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-07-22 |
Marketing Category | NDA |
Application Number | NDA019123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-06-23 |
Marketing Category | NDA |
Application Number | NDA019123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-06-23 |
Marketing Category | NDA |
Application Number | NDA019123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-06-23 |
Marketing Category | NDA |
Application Number | NDA019123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-07-07 |
Marketing Category | NDA |
Application Number | NDA019123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-06-21 |
Marketing Category | NDA |
Application Number | NDA019123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-02-04 |
Marketing Category | NDA |
Application Number | NDA019123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-07-20 |
Ingredient | Strength |
---|---|
POTASSIUM CHLORIDE | 750 mg/1 |
SPL SET ID: | e02f9d3e-d744-4020-b90c-215f2ae69e16 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0440-8110 | Klor-Con | Klor-Con |
0615-8045 | KLOR-CON | KLOR-CON |
43353-064 | KLOR-CON | KLOR-CON |
0245-0041 | Klor-Con | Klor-Con |
0245-0040 | Klor-Con | Klor-Con |
0245-0360 | KLOR-CON | KLOR-CON |
55154-0927 | KLOR-CON | KLOR-CON |
55289-697 | Klor-Con | Klor-Con |
65084-464 | KLOR-CON | KLOR-CON |
65084-465 | KLOR-CON | KLOR-CON |
66758-160 | KLOR-CON | KLOR-CON |
66758-110 | KLOR-CON | KLOR-CON |
67544-237 | Klor-Con | Klor-Con |
67544-154 | Klor-Con | Klor-Con |
0245-5315 | KLOR-CON | KLOR-CON |
0245-5316 | KLOR-CON | KLOR-CON |
0074-3023 | K-Tab | Potassium Chloride |
0074-3058 | K-Tab | Potassium Chloride |
0074-3278 | K-Tab | Potassium Chloride |
0074-7804 | K-Tab | Potassium Chloride |
0220-2891 | Kali muriaticum | POTASSIUM CHLORIDE |
0220-2951 | Kali muriaticum | POTASSIUM CHLORIDE |
0220-2952 | Kali muriaticum | POTASSIUM CHLORIDE |
0220-2953 | Kali muriaticum | POTASSIUM CHLORIDE |
0220-2954 | Kali muriaticum | POTASSIUM CHLORIDE |
0220-2955 | Kali muriaticum | POTASSIUM CHLORIDE |
0220-2956 | Kali muriaticum | POTASSIUM CHLORIDE |
0220-2957 | Kali muriaticum | POTASSIUM CHLORIDE |
0121-0841 | Potassium Chloride | POTASSIUM CHLORIDE |
0121-1680 | Potassium Chloride | POTASSIUM CHLORIDE |
0121-2520 | Potassium Chloride | POTASSIUM CHLORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
KLOR-CON 73592767 1415559 Live/Registered |
UPSHER-SMITH LABORATORIES, INC. 1986-04-11 |
KLOR-CON 73173477 1112591 Dead/Cancelled |
UPSHER-SMITH LABORATORIES, INC. 1978-08-04 |